NASH: bariatric surgery and major adverse liver and cardiovascular outcomes

In this retrospective cohort study of 1158 patients with biopsy-proven fibrotic NASH without cirrhosis, bariatric surgery was significantly associated with a lower risk of major adverse liver outcomes.